Does anti-aggregation with dipyridamole and aspirin help to prolong the primary patency of vascular access grafts? You have full access to this article via your institution. Patent vascular access ...

Hemodialysis vascular access dysfunction, which causes considerable morbidity, often results from venous stenosis followed by thrombosis in polytetrafluoroethylene (PTFE) grafts. Vascular ...

Vascular Grafts Market by Product Type (Endovascular Grafts [Abdominal and Thoracic], Access Grafts, Peripheral Grafts, and Others) . Vascular Grafts Market by Type (Knitted, Woven, and Others) ...

Trusted for more than 20 years, HEMASHIELD grafts are the most used, most studied vascular products available in the market today. More than 2 million HEMASHIELD grafts have been implanted ...

LifeSpan ePTFE Vascular Grafts for peripheral vascular reconstructions and AV Access have been used in clinical practice for more than 15 years. It features soft ePTFE material with superb suture ...

Cite this: Technology Insight: The Evolution of Tissue-Engineered Vascular Grafts--From Research to Clinical Practice - Medscape - Jul 01, 2007. The recent transition to clinical use by two ...

Xeltis has hit two milestones for its vascular access conduit, with one coming in the regulatory arena and the other in the device’s clinical journey. The Dutch company shared that the US Food ...

This seems like an interesting alternative to relying on synthetic grafts or the ... limb ischemia via expanded access. Here in Atlanta, I have a close friend with vascular disease who's faring ...